MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

08 Nov 2024 Evaluate
The September 2024 quarter revenue stood at Rs. 1967.48 millions, up 18.06% as compared to Rs. 1666.44 millions during the corresponding quarter last year.Net profit stood at Rs. 142.57  millions  compared to Rs. 120.48 millions in the corresponding previous quarter,high by 18.33%.Operating profit for the quarter ended September 2024 rose to 331.65 millions as compared to 286.33 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1967.48 1666.44 18.06 3611.99 3019.83 19.61 7092.63 5220.51 35.86
Other Income 13.05 8.10 61.11 26.73 13.23 102.04 44.60 49.14 -9.24
PBIDT 331.65 286.33 15.83 679.98 558.03 21.85 1213.04 595.88 103.57
Interest 46.06 55.72 -17.34 92.73 118.95 -22.04 234.57 219.13 7.05
PBDT 285.59 230.61 23.84 587.25 439.08 33.75 978.47 376.75 159.71
Depreciation 86.20 79.00 9.11 170.02 155.91 9.05 315.16 321.25 -1.90
PBT 199.39 151.61 31.52 417.23 283.17 47.34 663.31 55.50 1095.15
TAX 56.82 31.13 82.52 111.38 69.87 59.41 169.07 14.65 1054.06
Deferred Tax 9.82 0.13 7453.85 11.38 4.87 133.68 17.79 14.69 21.10
PAT 142.57 120.48 18.33 305.85 213.30 43.39 494.24 40.85 1109.89
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 16.86 17.18 -1.89 18.83 18.48 1.88 17.10 11.41 49.84
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..